Virginia 2026 Regular Session

Virginia Senate Bill SB138

Introduced
1/6/26  
Refer
1/6/26  
Refer
1/6/26  
Report Pass
2/3/26  
Report Pass
2/10/26  
Engrossed
2/12/26  
Refer
2/18/26  
Report Pass
2/25/26  
Report Pass
3/2/26  
Enrolled
3/11/26  
Chaptered
4/13/26  

Caption

PFAS monitoring; DEQ to require for industrial wastewater source, publicly owned treatment works.

Impact

The implementation of SB138 is expected to enhance state regulations concerning water safety and the control of toxic substances. By instituting stringent monitoring requirements, the bill aims to mitigate the risks associated with PFAS, which have been linked to various adverse health effects. Facilities including textile mills, electroplating plants, and airports are specifically targeted, and proactive measures are encouraged to address potential contamination sources. This legislation is anticipated to bring the state's environmental standards more in line with emerging scientific understanding of PFAS and its impact on public health.

Summary

SB138 mandates the monitoring of per- and polyfluoroalkyl substances (PFAS) in wastewater discharges from various industrial sources to ensure water quality protection. Specifically, the bill requires industrial facilities that produce or utilize PFAS to conduct quarterly discharge monitoring and report the results to the Department of Environmental Quality (DEQ) for a period of one year. The legislation aims to identify significant sources of PFAS contamination within publicly owned treatment works, thereby facilitating effective management of these harmful substances in the environment.

Sentiment

The general sentiment surrounding SB138 appears to be supportive among environmental advocates and public health organizations, as it represents a step towards greater accountability and safety in industrial practices. Proponents argue that the monitoring requirements are crucial for protecting public water systems from harmful pollutants. However, there may be concerns raised by industries affected by these regulations, which could view the monitoring requirements as an additional compliance burden. The bill's passage demonstrates a commitment by the legislature to prioritize environmental health and safety in light of growing concerns over PFAS pollution.

Contention

While SB138 has received broad support, it may also face opposition from sectors that fear the financial implications of enhanced monitoring and reporting obligations. Industries may argue for a phased approach to monitoring or seek more clarity on compliance standards to mitigate the economic impact. Notably, the bill includes provisions that allow for the review of monitoring frequency based on initial results, which could lead to debates regarding the adequacy of these stipulations to balance regulatory enforcement with economic realities.

Companion Bills

No companion bills found.

Previously Filed As

VA SB1319

Industrial wastewater; publicly owned treatment works.

VA HB2050

Occoquan Reservoir PFAS Reduction Program; established.

VA HB2178

Discharging preproduction plastic; regulation, requirements.

VA HB2649

Prescription Monitoring Program; exemptions, licensed narcotic maintenance treatment programs.

VA HB1842

Industrial development authorities; Town of Front Royal.

VA HB2307

Prescription Monitoring Program; requirements of practitioners, pharmacy technicians, training prog.

VA HB2677

Dinwiddie Airport and Industrial Authority; residency requirements.

VA SB446

Environmental Resources, Board of; created.

VA SB332

Misdemeanor; maximum term of confinement.

VA HB1185

Prescription Monitoring Program; overdose information.

Similar Bills

GA SB538

"Forever Chemicals Transparency Act"; enact

GA HB611

Forever Chemicals Transparency Act; enact

VA HB938

PFAS monitoring; DEQ to require for industrial wastewater source, publicly owned treatment works.

VA SB1319

Industrial wastewater; publicly owned treatment works.

ME LD465

An Act to Update Waste Discharge License Fees